Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tevogen Bio Holdings Inc. - Common Stock
(NQ:
TVGN
)
1.000
+0.150 (+17.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
10,794,160
Open
1.200
Bid (Size)
0.9400 (6)
Ask (Size)
1.000 (245)
Prev. Close
0.8500
Today's Range
0.9300 - 1.200
52wk Range
0.8030 - 21.09
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's After-Market Session
April 26, 2024
Via
Benzinga
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 26, 2024
Via
Benzinga
Performance
YTD
-90.00%
-90.00%
1 Month
-73.33%
-73.33%
3 Month
-90.00%
-90.00%
6 Month
-90.00%
-90.00%
1 Year
-90.00%
-90.00%
More News
Read More
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
April 26, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 19, 2024
Via
Benzinga
Equifax Reports Weak Sales, Joins Synovus Financial And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
April 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
April 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 12, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
April 11, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Perion Network Cuts Sales Outlook, Joins Range Resources And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Via
Benzinga
Why Is TC Biopharm (TCBP) Stock Up 78% Today?
April 04, 2024
Via
InvestorPlace
HUBS Stock Alert: HubSpot Surges on Report Google Is Eyeing a Buy
April 04, 2024
Via
InvestorPlace
Why Is Tevogen Bio (TVGN) Stock Up 46% Today?
April 04, 2024
Via
InvestorPlace
Dow Jumps Over 100 Points; US Jobless Claims Increase To 221,000
April 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 04, 2024
Via
Benzinga
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
April 03, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price
March 28, 2024
From
Tevogen Bio Inc
Via
GlobeNewswire
Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant
March 20, 2024
From
Tevogen Bio
Via
Business Wire
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
March 13, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita
March 05, 2024
From
Tevogen Bio
Via
Business Wire
Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI
February 27, 2024
From
Tevogen Bio
Via
Business Wire
Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment
February 21, 2024
From
Tevogen Bio
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.